CALACalithera Biosciences, Inc.
0.0001USD0.00%Mkt Cap: 487 $P/E: —4d ago
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosc…
Industry Peers
Shell CompaniesKey Statistics
Company
Market Cap487 $
Enterprise Value-1.44M $
Revenue (TTM)—
Gross Profit-28.53M $
Net Income (TTM)-39.65M $
Revenue/Share—
Last Price0.0001 USD
Fiscal Year EndDec 2022
MR QuarterDec 2022
Employees8
CountryUS
SectorHealthcare
IndustryShell Companies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA0.03
EV/Revenue—
P/S—
P/B-0.00
EPS (TTM)-1.32
EPS (Forward)-1.35
52W Range
0.00010% of range0.0010
52W High0.0010 USD
52W Low0.0001 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-194.44%
ROA-138.27%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-43.61M $
CapEx (TTM)133.00K $
FCF Margin—
FCF Yield-5785266.94%
Net Debt-23.79M $
Net Debt/EBITDA0.57
Balance Sheet
Debt/Equity0.08
Current Ratio3.60
Quick Ratio3.44
Book Value/Sh-0.4010 USD
Cash/Share5.223 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJun 15, 2022
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.87M
Float4.83M
Insiders0.00%
Institutions0.00%
Short Interest
Short Ratio0.8d
Short % Float8.92%
Short % Out.8.57%
Shares Short417.28K
Short (prev mo.)148.51K
Technical
SMA 500.0003 (-61.2%)
SMA 2000.0003 (-63.5%)
Beta-1.22
S&P 52W Chg18.16%
Avg Vol (30d)106
Avg Vol (10d)15
Technical Indicators
RSI (14)28.3
MACD-0.0000
MACD Signal-0.0000
MACD Hist.-0.0000
BB Upper0.0004 USD
BB Middle0.0002 USD
BB Lower-0.0000 USD
BB Width205.20%
ATR (14)0.0000 USD
Vol Ratio (20d)0.00x